Aromatic-dependent Salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them

被引：33

作者：

Stocker, BAD ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA

来源：

JOURNAL OF BIOTECHNOLOGY | 2000年 / 83卷 / 1-2期

关键词：

salmonella; typhoid; vaccine;

D O I：

10.1016/S0168-1656(00)00297-2

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The development of live bacterial vaccines is reviewed, in particular aromatic-dependent Salmonella, either for protection against the corresponding infections (including typhoid fever) or as carrier-presenter of antigens of unrelated pathogens or of DNA specifying them. Aromatic-dependent Salmonella live vaccines are also compared with BCG and Ty21a and the recent records of exceptional situations are discussed in which aroA (deletion) strains of Salmonella typhimurium cause progressive disease in mice. (C) 2000 Elsevier Science B.V. All rights reserved.

引用

页码：45 / 50

页数：6

共 28 条

[1] STUDIES ON MALARIAL PARASITES .8. FACTORS AFFECTING THE GROWTH OF PLASMODIUM KNOWLESI INVITRO [J].

ANFINSEN, CB ;

GEIMAN, QM ;

MCKEE, RW ;

ORMSBEE, RA ;

BALL, EG .

JOURNAL OF EXPERIMENTAL MEDICINE, 1946, 84 (06) :607-621

[2]

BACON GA, 1951, BRIT J EXP PATHOL, V32, P85

[3]

BACON GA, 1950, BRIT J EXP PATHOL, V31, P714

[4]

BACON GA, 1950, BRIT J EXP PATHOL, V31, P703

[5]

BODHIDATTA L, 1987, REV INFECT DIS, V9, P841

[6]

BROUGHTONALCOCK W, 1912, LANCET, V2, P504

[7] SALMONELLA-TYPHI-205ATY, A STRAIN WITH 2 ATTENUATING AUXOTROPHIC CHARACTERS, FOR USE IN LABORATORY TEACHING [J].

BROWN, RF ;

STOCKER, BAD .

INFECTION AND IMMUNITY, 1987, 55 (04) :892-898

[8] EXPRESSION OF THE ENVELOPE ANTIGEN OF DENGUE VIRUS IN VACCINE STRAINS OF SALMONELLA [J].

COHEN, S ;

POWELL, CJ ;

DUBOIS, DR ;

HARTMAN, A ;

SUMMERS, PL ;

ECKELS, KH .

RESEARCH IN MICROBIOLOGY, 1990, 141 (7-8) :855-858

[9] Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S-typhi vaccines;: effect of formulation on safety and immunogenicity [J].

Dilts, DA ;

Riesenfeld-Örn, I ;

Fulginiti, JP ;

Ekwall, E ;

Granert, C ;

Nónenmacher, J ;

Brey, RN ;

Cryz, SJ ;

Karlsson, K ;

Bergman, K ;

Thompson, T ;

Hu, B ;

Brückner, AH ;

Lindberg, AA .

VACCINE, 2000, 18 (15) :1473-1484

[10]

Engels EA, 1998, BRIT MED J, V316, P110, DOI 10.1136/bmj.316.7125.110

← 1 2 3 →